SITAGLIPTIN, A DIPEPTIDYL PEPTIDASE-4 INHIBITOR, CAN PREVENT THE EXPRESSION OF OXIDATIVE STRESS DUE TO DECREASING SERUM FERRITIN LEVEL.

被引：0
|
作者：
Fukunishi, Shinya [1 ]
Yokohama, Keisuke [1 ]
Nakamura, Ken [1 ]
Ohama, Hideko [1 ]
Tsuchimoto, Yusuke [1 ]
Okamoto, Norio [1 ]
Matsui, Masahiro [1 ]
Yasuoka, Hidetaka [1 ]
Nishikawa, Tomohiro [1 ]
Asai, Akira [1 ]
Higuchi, Kazuhide [1 ]
机构：
[1] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2271
引用
收藏
页码：1335A / 1335A
页数：1
相关论文
共 50 条
  • [1] Oral ulceration due to a dipeptidyl peptidase-4 inhibitor (sitagliptin): Report of a case
    Jinbu, Yoshinori
    Sase, Miwako
    Kashimura, Kei
    Itoh, Hiroto
    Kusama, Mikio
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2013, 25 (02) : 164 - 166
  • [2] The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice
    Al Suleimani, Yousuf M.
    Abdelrahman, Aly M.
    Karaca, Turan
    Manoj, Priyadarsini
    Ashique, Mohammed
    Nemmar, Abderrahim
    Ali, Badreldin H.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1102 - 1108
  • [3] Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor
    Bergman, Arthur J.
    Cote, Josee
    Yi, Bingming
    Marbury, Thomas
    Swan, Suzanne K.
    Smith, William
    Gottesdiener, Keith
    Wagner, John
    Herman, Gary A.
    DIABETES CARE, 2007, 30 (07) : 1862 - 1864
  • [4] The Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Gentamicin Nephrotoxicity in Mice
    Ali, Badreldin H.
    Suleimani, Yousuf M.
    Abdelrahman, Aly M.
    Karaca, Turan
    Nemmar, Abderrahim
    FASEB JOURNAL, 2018, 32 (01):
  • [5] Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers
    Bergman, Arthur
    Ebel, David
    Liu, Fang
    Stone, Julie
    Wang, Amy
    Zeng, Wei
    Chen, Li
    Dilzer, Stacy
    Lasseter, Kenneth
    Herman, Gary
    Wagner, John
    Krishna, Rajesh
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) : 315 - 322
  • [6] Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, (R)-Sitagliptin
    Anjibabu, Ramisetti
    Boggu, Jagan Mohan Reddy
    Shekhar, Putta
    Reddy, Basi V. Subba
    CHEMISTRYSELECT, 2016, 1 (17): : 5445 - 5447
  • [7] Sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Can Be Effective Drug for Hepatic Iron Metabolism
    Fukunishi, Shinya
    Asai, Akira
    Tsuda, Yasuhiro
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2016, 150 (04) : S601 - S601
  • [8] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [9] Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
    Gault, V. A.
    Lennox, R.
    Flatt, P. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 403 - 413
  • [10] Effects of the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, on Colorectal Carcinogenesis in a Model of Type 2 Diabetes
    Inoue, Takuya
    Yorifuji, Naoki
    Fujiwara, Kaori
    Sakanaka, Taisuke
    Iguchi, Munetaka
    Narabayashi, Ken
    Okada, Toshihiko
    Nouda, Sadaharu
    Kakimoto, Kazuki
    Ishida, Kumi
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Umegaki, Eiji
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2014, 146 (05) : S654 - S655
12345